Mesoblast (MEOBF) Revenue (2014 - 2023)

Mesoblast has disclosed Revenue across 10 years of filings, most recently posting $1.9 million for Q2 2023.

• In Q2 2023, Revenue fell 7.76% year-over-year to $1.9 million; the TTM figure through Jun 2023 stood at $7.4 million (down 33.37% YoY), while the FY2026 annual figure was $120.2 million, up 599.21% from the prior year.
• Revenue came in at $1.9 million for Q2 2023 at Mesoblast, down from $1.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $31.5 million in Q1 2020 to a low of $1.2 million in Q1 2019.
• Average Revenue over 5 years is $4.8 million, with a median of $2.0 million recorded in 2022.
• Year-over-year, Revenue jumped 2418.41% in 2020 and plunged 93.91% in 2021.
• Over 5 years, Revenue stood at $3.6 million in 2019, then tumbled by 37.92% to $2.2 million in 2020, then soared by 57.79% to $3.5 million in 2021, then slumped by 39.65% to $2.1 million in 2022, then decreased by 13.07% to $1.9 million in 2023.
• Per Business Quant data, the three most recent Revenue figures were $1.9 million in Q2 2023, $1.9 million in Q1 2023, and $2.1 million in Q4 2022.